Jiangsu Province Centers for Disease Control and Prevention
Establishment time : 1967
website : http://www.jscdc.cn/
Main Product : Disease prevention and control services, public health education, epidemiological investigation
Company Profile
Jiangsu Province Centers for Disease Control and Prevention is a government agency responsible for disease prevention and control, public health education, and epidemiological investigation in Jiangsu Province, China. Established in 1967, the organization plays a crucial role in safeguarding the health of the population and preventing the spread of infectious diseases. With a medium-sized team and strong government support, the Jiangsu CDC is a leading public health organization in the region. Visit their website at http://www.jscdc.cn/ for more information.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : Chengdu Institute of Biological Products Co., Ltd. was founded in 1967.
website : http://www.cibp.com.cn/.
Main Product : They specialize in the production of vaccines, blood products, and diagnostic reagents.
Company Profile
Overall, Chengdu Institute of Biological Products Co., Ltd. is a reputable and established biopharmaceutical company.
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2007
website : www.chengdabio.com
Main Product : Probiotics, feed additives, veterinary drugs
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. was founded in 2007 and specializes in the production and distribution of probiotics, feed additives, and veterinary drugs. With a focus on quality and innovation, the company has grown to become a key player in the biotechnology industry, serving customers in China, Southeast Asia, and the Middle East. Chengda Biotechnology is known for its high-quality products and commitment to customer satisfaction.
Wuhan Institute of Biological Products Co., Ltd.
Establishment time : Founded in 1950.
website : http://www.whbp.com.cn/
Main Product : Vaccines, biological products, and pharmaceuticals.
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. With a history of over 70 years, the company has established a strong presence in both domestic and international markets, providing high-quality and affordable healthcare solutions to customers worldwide.
Changchun BCHT Biotechnology Co., Ltd.
Establishment time : 2003
website : www.bchtbiotech.com
Main Product : vaccines, diagnostic kits, biological products
Company Profile
Changchun BCHT Biotechnology Co., Ltd. was founded in 2003 and has since become a leading manufacturer of vaccines, diagnostic kits, and biological products. With a strong presence in the domestic market, the company has been expanding its reach into international markets in recent years. Despite facing increasing competition, BCHT Biotechnology continues to innovate and provide high-quality products to its customers.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Sinovac Biotech Co., Ltd.
Establishment time : 2001
website : www.sinovac.com
Main Product : COVID-19 vaccine, influenza vaccine, hepatitis A and B vaccines
Company Profile
Sinovac Biotech Co., Ltd. is a leading biopharmaceutical company specializing in the research, development, production, and commercialization of vaccines. Founded in 2001, the company has grown to become a key player in the global vaccine market, with a focus on preventing infectious diseases. With a diverse portfolio of vaccines, Sinovac is dedicated to improving public health and saving lives through its innovative products.
Hualan Biological Engineering Inc.
Establishment time : Hualan Biological Engineering Inc. was founded in 1992.
website :
Main Product : With a medium-sized company size, Hualan Biological Engineering Inc. has established a strong presence in the Chinese market.
Company Profile
Hualan Biological Engineering Inc. continues to innovate and expand its product offerings to meet the needs of its customers.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992.
website :
Main Product : With over 3,000 employees, Kangtai is one of the largest biopharmaceutical companies in China.
Company Profile
For more information, visit the company's website at www.kangtai-bio.com.
